Skip to main content
. 2019 Nov 11;41(8):943–954. doi: 10.1093/eurheartj/ehz769

Figure 1.

Figure 1

Two-year unadjusted clinical outcomes. Crude Kaplan–Meier failure rates according to angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment at baseline in patients undergoing transcatheter aortic valve replacement. (A) All-cause death, (B) cardiovascular death, and (C) non-cardiovascular death. CI, confidence interval; HR, hazard ratio.